Index Pharmaceuticals Ab Is A Swedish Biopharmaceutical Company Based In Solnafocused On Developing Innovative Therapies For Immunological Diseasesparticularly Inflammatory Bowel Conditions Like Ulcerative Colitisthe Company Is Dedicated To Addressing High Unmet Medical Needs Through Its Drug Development Efforts One Of Its Key Products Is Cobitolimoda Dna Based Anti Inflammatory Compound Designed For Treating Moderate To Severe Ulcerative Colitisindex Pharmaceuticals Ab Collaborates With Clinical Research Organizations And Healthcare Institutions To Advance Its Drug Development Initiativesthe Company Is Led By Ceo Peter Zerhouniwho Emphasizes The Importance Of Meeting Unmet Medical Needs In The Field Of Immunology
No conferences found for this company.
| Company Name | Index Pharmaceuticals Ab |
| Country |
Sweden
|
| Address | N/A |
| Telephone | N/A |
| N/A |
